HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia.

AuthorsParameswaran Anoop, Andy Wotherspoon, Estella Matutes
JournalBritish journal of haematology (Br J Haematol) Vol. 148 Issue 3 Pg. 484-6 (Feb 2010) ISSN: 1365-2141 [Electronic] England
PMID19874308 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Adult
  • Alemtuzumab
  • Antibodies, Monoclonal (adverse effects)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (adverse effects)
  • Antineoplastic Agents (adverse effects)
  • Hepacivirus (physiology)
  • Hepatitis C (immunology)
  • Humans
  • Immunocompromised Host
  • Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy)
  • Male
  • Virus Activation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: